At a glance
ClinicalIndex Comparison Record- ✓Age 13 to 35 years
- ✓Good health with no other facial skin disorders interfering with acne assessments
- ✓Minimum 5 inflammatory lesions (papules/pustules) on each side of face with at least one ≥2 mm diameter visible on digital imaging
- ✓Minimum 5 non-inflammatory lesions (comedones) on each side of face with lesions relatively symmetrical
- ✕No inflammatory acne or only non-inflammatory acne
- ✕Presence of acne cysts or nodules
- ✕Severe acne forms: acne conglobata, acne fulminans, secondary acne, or acne requiring systemic treatment
- ✕Excessive facial hair interfering with assessments
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Split-Face, Paired-Comparison, Pilot Study to Evaluate Safety and Efficacy of Two Topical Salicylic Acid 1.0% Creams for Mild to Moderate Acne Vulgaris
In Brief
A clinical study evaluating Formulation A and Formulation B for Acne Vulgaris. Completed, enrolled 10 participants across 1 site.
Detailed Summary
This study is a split face, paired-comparison, pilot study of at least 10 subjects to complete. Participants in this study will be patients seen at Children's Memorial Hospital, who are clinically diagnosed with mild to moderate acne vulgaris. Participants will be recruited from one of the clinics, as well as from previous Institutional Review Board (IRB) approved acne studies housed in the Department of Dermatology. All subjects accrued from previous studies have agreed to be contacted for further investigations. Subjects 13 to 35 years of age with mild to moderate acne vulgaris symmetrical in appearance on both sides of the face, and meeting inclusion criteria will be eligible to participate
Study Details
Timeline
Interventions
Formulation A will be applied to the randomly-assigned single (left or right) side of the face twice daily.
Formulation B will be applied to the randomly-assigned single (left or right) side of the face twice daily.